MedTrace Logo

Cardiac Arrhythmias in Greenland

NCT05200676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-03-15

No results posted yet for this study

Summary

The study is a phd-study comprising several substudies focusing on cardiac arrhythmias, mainly atrial fibrillation, among Greenlanders in Greenland.

Some previous studies have indicated that the prevalence may be lower than among Westerners, however; studies have also indicated that atrial fibrillation is underdiagnosed.

These studies aim to:

* Estimate the prevalence of AF among Greenlanders in Greenland aged 55 years or older.
* Estimate the prevalence of well-known risk factors among those found to have AF
* Explore the symptoms of those affected by AF in Greenland
* Among part of the participants: estimate the prevalence of autonomic neuropathy as this may cause arrhythmias.

Conditions

Interventions

DEVICE

ePatch

ePatch registers the heart rate continuously when attached to the chest of the participant.

DEVICE

SmartPill

SmartPill is swallowed and passes through the digestive system while sending information to a recording device. The pill is passed in the stool and not reused.

Sponsors & Collaborators

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Nadja Albertsen, MD, PhD · Aalborg University / University of Greenland and Aalborg University Hospital

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-16
Primary Completion
2023-03-28
Completion
2024-03-11

Countries

  • Greenland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05200676 on ClinicalTrials.gov